These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4120682)

  • 1. Melanocyte-stimulating hormone and parkinsonism: the role of hypothalamic releasing factors.
    Sandler M; Goodwin BL; Leask BG; Ruthven CR
    Lancet; 1973 Mar; 1(7803):612. PubMed ID: 4120682
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypothalamic releasing factors and Parkinson disease.
    Chase TN; Woods AC; Lipton MA; Morris CE
    Arch Neurol; 1974 Jul; 31(1):55-6. PubMed ID: 4209275
    [No Abstract]   [Full Text] [Related]  

  • 3. Melanocyte-stimulating hormone and the hypothalamic hormone which inhibits its release.
    Kastin AJ; Barbeau A; Ehrensing RH; Plotnikoff NP; Schally AV
    Adv Neurol; 1974; 5():225-9. PubMed ID: 4216256
    [No Abstract]   [Full Text] [Related]  

  • 4. Formation of a melanocyte-stimulating hormone-release inhibiting factor by hypothalamic extracts from rats.
    Celis ME; Taleisnik S
    Int J Neurosci; 1971 Apr; 1(4):223-30. PubMed ID: 4949884
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypothalamic control of anterior pituitary hormone secretion--characterized hypothalamic-hypophysiotropic peptides.
    Grant GF; Vale W
    Curr Top Exp Endocrinol; 1974; 2():37-72. PubMed ID: 4208407
    [No Abstract]   [Full Text] [Related]  

  • 6. [Recent acquisitions concerning hypothalamic regulation of anterior pituitary function].
    Rozenberg I; Usategui Echeverria R; Oliver C; Lombardi G; Vaudry H; Mourre AM; Vague J
    Recenti Prog Med; 1976 Oct; 61(4):535-56. PubMed ID: 16320
    [No Abstract]   [Full Text] [Related]  

  • 7. [Progress in the study of hypothalamic hormones].
    Ito T
    Horumon To Rinsho; 1975 Jan; 23(1):1-5. PubMed ID: 168014
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hypothalamic releasing hormones. I. Structure, sources of formation, physiologic effects].
    Dedov II; Dedov VI
    Usp Sovrem Biol; 1980; 89(1):141-58. PubMed ID: 6104883
    [No Abstract]   [Full Text] [Related]  

  • 9. Pituitary-hypothalamic dysfunction in generalized lipodystrophy.
    Mabry CC; Hollingsworth DR; Upton GV; Corbin A
    J Pediatr; 1973 Apr; 82(4):625-33. PubMed ID: 4121462
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypothalamic control of adenohypophysial secretions.
    Blackwell RE; Guillemin R
    Annu Rev Physiol; 1973; 35():357-90. PubMed ID: 4350616
    [No Abstract]   [Full Text] [Related]  

  • 11. Action of two hypothalamic factors (TRH, MIF) and of angiotensin II on the behavioral effects of L-DOPA and 5-hydroxytryptophan in mice.
    Huidobro-Toro JP; De Carolis AS; Longo VG
    Pharmacol Biochem Behav; 1974; 2(1):105-9. PubMed ID: 4364044
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hypothalamic control of pituitary function with special reference to reproduction. Clinical and experimental studies].
    Schally AV
    Rev Iber Endocrinol; 1972; 19(114):517-37. PubMed ID: 4629595
    [No Abstract]   [Full Text] [Related]  

  • 13. Melanocyte-stimulating hormone-releasing and inhibiting factors in two hypothalamic extracts.
    Taleisnik S; Tomatis ME
    Endocrinology; 1967 Oct; 81(4):819-25. PubMed ID: 4292488
    [No Abstract]   [Full Text] [Related]  

  • 14. 13C nuclear magnetic resonance studies of the conformation of the X-pro bond in the oligopeptide hormones, thyrotropin-releasing hormone, luteinizing hormone-releasing factor, angiotensin and melanocyte-stimulating hormone release-inhibiting factor.
    Deslauriers R; Walter R; Smith IC
    Biochem Biophys Res Commun; 1973 Jul; 53(1):244-50. PubMed ID: 4354931
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hypophyseotropic hypothalamus hormones].
    Winkelmann W
    Internist (Berl); 1971 May; 12(5):193-8. PubMed ID: 4325460
    [No Abstract]   [Full Text] [Related]  

  • 16. Melanocyte-stimulating hormone and parkinsonism.
    Robins AH
    Lancet; 1973 Mar; 1(7805):727. PubMed ID: 4120529
    [No Abstract]   [Full Text] [Related]  

  • 17. DOPA potentiation by a hypothalamic factor, MSH release-inhibiting hormone (MIF).
    Plotnikoff NP; Kastin AJ; Anderson MS; Schally AV
    Life Sci I; 1971 Nov; 10(22):1279-83. PubMed ID: 4947365
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemistry of the hypothalamic releasing factors--studies on structure-function relationships.
    Vale W; Grant G; Guillemin R
    Front Neuroendocrinol; 1973; 0(0):375-413. PubMed ID: 4369859
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanism of action of hypothalamic hormones in the adenohypophysis.
    Labrie F; Borgeat P; Drouin J; Beaulieu M; Lagacé L; Ferland L; Raymond V
    Annu Rev Physiol; 1979; 41():555-69. PubMed ID: 219766
    [No Abstract]   [Full Text] [Related]  

  • 20. Melanocyte-stimulating hormone and parkinsonism.
    Shuster S; Thody AJ; Goolamali SK; Burton JL; Plummer N; Bates D
    Lancet; 1973 Mar; 1(7801):463-4. PubMed ID: 4120371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.